Oncosec Medical Stock Beta
| ONCSDelisted Stock | USD 0.06 0 3.63% |
OncoSec Medical fundamentals help investors to digest information that contributes to OncoSec Medical's financial success or failures. It also enables traders to predict the movement of OncoSec Stock. The fundamental analysis module provides a way to measure OncoSec Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OncoSec Medical stock.
OncoSec |
OncoSec Medical Company Beta Analysis
OncoSec Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current OncoSec Medical Beta | 2.0 |
Most of OncoSec Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OncoSec Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, OncoSec Medical has a Beta of 1.9989. This is 132.43% higher than that of the Biotechnology sector and 43.81% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
OncoSec Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OncoSec Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics of similar companies.OncoSec Medical is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OncoSec Medical will likely underperform.
OncoSec Fundamentals
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 5.6 M | |||
| Shares Outstanding | 5.96 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 5.83 % | |||
| Number Of Shares Shorted | 192.06 K | |||
| Price To Earning | (3.12) X | |||
| Price To Book | 0.78 X | |||
| EBITDA | (35.92 M) | |||
| Net Income | (34.18 M) | |||
| Cash And Equivalents | 19.48 M | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 6.17 M | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 4.51 X | |||
| Book Value Per Share | (1.85) X | |||
| Cash Flow From Operations | (32.14 M) | |||
| Short Ratio | 0.34 X | |||
| Earnings Per Share | (20.31) X | |||
| Target Price | 110.0 | |||
| Number Of Employees | 40 | |||
| Beta | 2.0 | |||
| Market Capitalization | 1.65 M | |||
| Total Asset | 21.88 M | |||
| Retained Earnings | (285.96 M) | |||
| Working Capital | 8.6 M | |||
| Current Asset | 29.42 M | |||
| Current Liabilities | 3.47 M | |||
| Z Score | -23.08 | |||
| Net Asset | 21.88 M |
About OncoSec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |